INTRODUCTION
Synaptic cell-adhesion molecules (CAMs) are major synapse organizers that initiate the cell-type-specific formation of nascent synaptic contacts and recruit the pre-and postsynaptic protein complexes required for proper synaptic signaling (Missler et al., 2012) . The list of synaptic CAMs has rapidly grown, largely reflecting the development of the heterologous synapse formation assay (Biederer and Scheiffele, 2007) . Neuroligins (NLs), SynCAMs, netrin-G ligands, SALM3 and SALM5, leucine-rich repeat transmembrane proteins (LRRTMs), and Slit-and Trk-like (Slitrks) proteins are among the synaptogenic CAMs with established synaptic functions (Missler et al., 2012; Sü dhof, 2008; Um and Ko, 2013) . However, considering the number of neuronal synapses and neural circuits in the brain, it is reasonable to propose that additional synaptogenic CAMs remain undefined.
Calsyntenins (CSTs), also called alcadeins, are members of the cadherin superfamily (Araki et al., 2003; Vogt et al., 2001) . Originally identified from spinal-cord neurons (Vogt et al., 2001) , CSTs are type I transmembrane proteins with extracellular domains containing two cadherin repeats and a laminin-a, neurexin, and sex hormone-binding globulin (LNS) domain. These proteins comprise three members: CST-1 (alcadein-a), CST-2 (alcadein-g), and , and a single ortholog has also been identified in Caenorhabditis elegans (CASY-1 or CDH11) and Drosophila melanogaster (Cals) (Ikeda et al., 2008; Pettitt, 2005) . CSTs are widely expressed in the CNS (Hintsch et al., 2002; Vogt et al., 2001) . CST-1 is primarily expressed in the postsynaptic membranes of pyramidal neurons, whereas CST-2 and CST-3 are expressed in inhibitory neurons (Hintsch et al., 2002) . Interestingly, CASY-1 is essential for chemotaxis-associated learning (Hoerndli et al., 2009; Ikeda et al., 2008) , and CST-2 polymorphisms have been associated with human memory performance (Papassotiropoulos et al., 2006) . In addition, CSTs dock vesicular cargo to kinesin-1, thereby determining the identity of transported cargo molecules (Araki et al., 2007; Konecna et al., 2006; Maruta et al., 2012; Vagnoni et al., 2011) . More specifically, CST-1 mediates the transport of amyloid precursor protein (APP) via binding to X11/Mint and protects this protein from proteolytic processing during axonal transport (Suzuki et al., 2006; Vagnoni et al., 2012) . Intriguingly, several CST peptides have been frequently identified in the cerebrospinal fluid of Alzheimer's disease (AD) patients (Ringman et al., 2012; Yin et al., 2009) , and CST-3 accumulates in dystrophic neurites surrounding amyloid-b (Ab) plaques (Uchida et al., 2013) . Moreover, CST-1 regulates Ab production through the regulation of APP transport at axons (Vagnoni et al., 2012) . These data suggest that CST-associated molecular pathways might contribute to the pathogenic mechanisms underlying AD. However, the synaptic functions of CSTs have not been investigated.
Here, we characterized the effects of CSTs on the structure and function of synapses in hippocampal and somatosensory cortical layer II/III neurons in vivo. CST-3 specifically induced presynaptic differentiation. The simultaneous knockdown of all three CSTs, but not a single CST isoform, decreased inhibitory synapse densities in cultured hippocampal neurons. Strikingly, CST-deficient neurons were morphologically smaller, and the neuronal phenotype was completely restored through the exogenous expression of full-length CST proteins. Furthermore, the frequency of miniature inhibitory, but not excitatory, postsynaptic currents was specifically reduced in CST-deficient cultured hippocampal and somatosensory cortical neurons. Moreover, we observed that CST-3 forms functional (but not physical) complexes with Nrxs. These data suggest that CST-3 is a synaptogenic adhesion molecule that forms functional complexes with Nrxs to regulate inhibitory synapse function.
RESULTS
Using heterologous synapse-formation assays with plasmid vectors expressing the entire extracellular region of cell-surface proteins exhibiting brain-specific expression (Table S1) , we screened for novel synaptogenic molecules that induce presynaptic differentiation (Biederer and Scheiffele, 2007) . The results revealed that LRRTMs, Slitrks, and TrkC act at the axons of cocultured neurons to specifically trigger presynaptic differentiation (Ko et al., 2009a; Yim et al., 2013) . In addition, the expression of CST-3 also showed synaptogenic activity.
CST-3 Triggers Presynaptic Differentiation
To determine the synaptic function(s) of CST-3, we first examined whether all three CSTs trigger presynaptic differentiation in heterologous synapse-formation assays using human embryonic kidney 293T (HEK293T) cells expressing each CST protein.
To maximize the cell-surface expression of CST proteins, we generated plasmids for the expression of full extracellular fragments of CSTs. CST-3, but not CST-1 or CST-2, strongly induced synapsin clustering (Figures 1A and 1B) . In parallel (A) CST-3 promotes the formation of excitatory and inhibitory presynapses in heterologous synapse-formation assays. Rat hippocampal neurons were cocultured for 3 days (DIV10-DIV13) with HEK293T cells expressing EGFP alone (control) or coexpressing EGFP and N-terminally HA-tagged CST-1 extracellular fragment (CST-1), CST-2 extracellular fragment (CST-2), CST-3 extracellular fragment (CST-3), or an mVenus-fusion protein of neuroligin-2 (NL2). The panels show representative immunofluorescence images of cocultures stained with antibodies to EGFP (green) and various presynaptic (VGLUT1, GAD67) and postsynaptic (PSD-95) markers (red). Coincident green and red signals are shown in yellow. The scale bar represents 20 mm (applies to all images). (B) Quantitation of the heterologous synapse-formation activity of CST-1, CST-2, CST-3, and NL2. To quantify the experiments described in (A), the ratio of the synaptic marker staining to EGFP fluorescence (from absolute red and green fluorescence values) was measured. All data are shown as means ± SEMs ( 3 *p < 0.001, assessed using ANOVA with Tukey's test; n denotes the total number of HEK293T cells analyzed, as follows: control/synapsin, n = 18; CST-1/synapsin, n = 21; CST-2/synapsin, n = 17; CST-3/synapsin, n = 16; NL2/synapsin, n = 14; control/VGLUT1, n = 22; CST-1/VGLUT1, n = 17; CST-2/ VGLUT1, n = 15; CST-3/VGLUT1, n = 15; NL2/VGLUT1, n = 16; control/ GAD67, n = 15; CST-1/GAD67, n = 15; CST-2/GAD67, n = 14; CST-3/GAD67, n = 15; NL2/GAD67, n = 14; control/PSD-95, n = 15; CST-1/PSD-95, n = 16; CST-2/PSD-95, n = 17; CST-3/PSD-95, n = 16; and NL2/PSD-95, n = 15).
experiments, CALS, the Drosophila ortholog of mammalian CSTs, did not induce synaptic clustering (data not shown). Similar to NL-2 (positive control), CST-3 induced the synaptic clustering of both the excitatory presynaptic marker vesicular glutamate transport 1 (VGLUT1) and the inhibitory presynaptic marker glutamic acid decarboxylase, 67 kDa (GAD67), but not the excitatory postsynaptic marker postsynaptic density, 95 kDa (PSD-95) ( Figures 1A and 1B) . These results suggest that CST-3 is a postsynaptogenic factor that induces presynaptic differentiation.
N-Terminal Cadherin Repeats Are Essential for the Presynapse-Inducing Activities of CST-3 CSTs possess two extracellular cadherin motifs (Cad repeats), a single LG/LNS domain, a transmembrane segment, and a short intracellular region comprising X11-and kinesin-binding sites (Araki et al., 2003; Vogt et al., 2001) . To determine the domains responsible for CST-3 synaptogenic activity, we performed heterologous synapse-formation assays using deletion constructs of CST-3 extracellular fragments ( Figure 2A ). Only CST-3 mutants containing both Cad repeats exhibited full synaptogenic activity in heterologous synapse-formation assays (Figures 2B and 2C) . Cadherin repeats typically mediate extracellular Ca 2+ -dependent homophilic adhesion; thus, we examined whether CSTs mediate homo-or heterophilic adhesion between CST family members using cell-adhesion and cellsurface-labeling assays ( Figure S1 ). We observed that CSTs showed no homo-or heterophilic adhesion activities, suggesting the existence of unidentified presynaptic ligand(s) for CSTs.
CST-3 mRNA and Protein Expression Patterns
Previous northern blot and in situ hybridization analyses of CSTs revealed that these proteins are located in postsynaptic membranes and are widely expressed in multiple brain regions (Hintsch et al., 2002; Vogt et al., 2001) . Intriguingly, although CST-1 is enriched in axonal growth cone vesicles in the developing brain, this protein is restricted to the postsynaptic membranes of excitatory and inhibitory synapses (Konecna et al., 2006; Vogt et al., 2001) . To determine whether other CST isoforms are also expressed in the developing brain, we performed in situ hybridization using mouse brain sections obtained from various embryonic and postnatal developmental stages (Figure 3A) . CST-1 mRNA was expressed through the entire body and more abundantly in the CNS ( Figure 3A) , consistent with the previously reported CST-1 expression pattern (Vogt et al., 2001) . In contrast, the distribution of CST-2 and CST-3 in E16-E18 mice was restricted to the CNS. In adult mouse brains, a strong CST-3 mRNA signal was observed in various brain areas, whereas CST-2 mRNA was locally distributed to brain regions, including the hippocampus and olfactory bulb ( Figure 3A) . To confirm the results obtained in the in situ hybridization analysis, we generated CST polyclonal CST-1/CST-2 antibodies (pan-antibody; JK010) and a CST-3-specific antibody (JK001) ( Figures 3B and 3C ). The CST-3 antibody (JK001) was used to confirm the authenticity of the immunoreactive signals using CST-3 knockout mouse lysates ( Figure 3D ). The expression of CST-1/CST-2 proteins abruptly increased between postnatal (A) Diagrams of the CST-3 variants used in heterologous synapse-formation assays. The full extracellular region of CST-3 (Ecto-full) carrying an HA epitope inserted after the signal peptide sequence was cloned into the pDisplay vector. CST-3 fragments carrying the following extracellular regions were also prepared as pDisplay vectors: Cad+LNS, a CST-3 fragment containing cadherin repeats and an LNS domain; LNS+linker, a CST-3 fragment containing the LNS domain and the linker region between an LNS domain and a transmembrane segment; Cad repeats, a CST-3 fragment containing two cadherin repeats; LNS, a CST-3 fragment containing the LNS domain; Cad repeat 1, a CST-3 fragment containing the first cadherin repeat; and Cad repeat 2, a CST-3 fragment containing the second cadherin repeat. (B and C) Synaptogenic activity of various CST-3 constructs (described in A) in heterologous synapse-formation assays. Representative immunofluorescence images of cocultures stained with antibodies to GFP (green) and synapsin (red). Coincident signals are shown in yellow. The scale bar represents 20 mm (applies to all images; B). Quantitation of heterologous synapse-formation assays (C), measured as the ratio of synapsin to GFP fluorescence signals. The dashed lines correspond to control values, used as the baseline. The data are shown as the means ± SEMs ( 3 *p < 0.001, assessed using ANOVA with Tukey's test; n denotes the total number of HEK293T cells analyzed, as follows: control, n = 15; Ecto-Full, n = 17; Cad+LNS, n = 17; LNS+linker, n = 16; Cad repeats, n = 14; LNS, n = 15; Cad repeat 19, n = 16; and Cad repeat 2, n = 16).
day 7 (P7) and P14, whereas CST-3 protein was steadily expressed throughout the postnatal development of mouse brains ( Figure 3E ). However, these antibodies were not suitable for immunocytochemistry; thus, we were unable to determine the synaptic localization of CSTs in cultured neurons (data not shown). All three CST proteins were significantly expressed (although not clearly enriched) in the PSD fraction ( Figure 3F ), consistent with previously reported biochemical data (Vogt et al., 2001) . Taken together, these results indicate that CST-3 is a PSD-localized synaptogenic adhesion molecule.
The Simultaneous Knockdown of All Three CSTs Decreases Inhibitory Synapse Density in Cultured Neurons
To determine whether CSTs are required for the maintenance of synapse structure, we generated a series of knockdown (KD) lentiviral vectors expressing short hairpin RNA (shRNA) targeting individual CSTs. Subsequently, we infected cultured mouse cortical neurons with these vectors and assessed the endogenous target mRNA levels using quantitative real-time . The shRNA suppressed endogenous mRNA expression $90% for CST-1, $80% for CST-2, and $85% for CST-3 ( Figure 4B ). We next investigated whether the single KD of CST-1, CST-2, or CST-3 altered the synapse number in cultured mouse hippocampal neurons. To this end, we infected cultured neurons at 3 days in vitro (DIV3) with lentiviruses expressing only enhanced GFP (EGFP) (control) or coexpressed EGFP with shRNAs against CST-1 (J73), CST-2 (J76), or CST-3 (J81). In addition, we immunostained neurons at DIV14 for synapsin and microtubule-associated protein 2 (MAP2) to visualize the entire somatodendritic architecture of the infected neurons ( Figure S2A ). We observed that single KD of each CST did not alter synapse density, synapse size, synapse strength, or soma size ( Figures S2B-S2E ), suggesting that either CSTs are not required for synapse maintenance or that CSTs are functionally redundant. To examine the potential functional redundancy of CSTs, we generated a triple-KD vector (CST-TKD) containing three human polymerase III promoters to drive the expression of shRNAs against all three CSTs and a ubiquitin promoter to drive expression of EGFP, facilitating the visualization of infected or transfected neurons ( Figure 4A ). Using the CST-TKD vector, which successfully suppressed the mRNA levels of all three CSTs ( Figure 4C ), we examined whether CSTs are functionally redundant and essential for synapse maintenance in cultured hippocampal neurons (Figures 4  and S3) . Strikingly, CST-TKD significantly decreased the number of inhibitory synapses, assessed using inhibitory synaptic markers (GAD67 and gephyrin; Figures 4D, 4E , and S3). CST-TKD also significantly reduced the number of excitatory presynaptic puncta (labeled by VGLUT1), but not excitatory postsynaptic puncta (labeled by Homer1) ( Figures 4D, 4E , and S3). These data suggest that CST-TKD preferentially alters inhibitory, but not excitatory, synapse structure in cultured hippocampal neurons. As previously reported, an LRRTM1 and LRRTM2 double-KD vector (LRRTM-DKD) did not alter the synapse density (Figures 4D and 4E ; . We also transfected cultured neurons at DIV8 with CST-TKD or an empty lentiviral shRNA vector (control) and immunostained neurons at DIV14 for synapsin and EGFP ( Figure S4 ). The introduction of the CST-TKD vector induced a modest but significant decrease in synapse number without changing synapse or soma size or any spine parameters (number, width, or length) ( Figures S4A-S4G ). Taken together, these results suggest that CSTs redundantly maintain synapses in cultured hippocampal neurons.
KD of CSTs Decreases the Soma Size of Cultured Hippocampal Neurons
An analysis of cultured mouse neurons infected with CST-TKD lentiviruses showed a dramatic reduction in the soma size of CST-TKD-infected neurons compared with control or LRRTM-DKD-infected neurons ( Figures 4D and 4F) . Moreover, electrophysiology recordings in cultured hippocampal neurons revealed that CST-TKD caused a significant decrease in membrane capacitance (C m ) and a concomitant increase in input resistance (R m ) ( Figures S5A and S5B ). These results imply that CSTs might stimulate the development of hippocampal neurons during the early stages of development. To examine this hypothesis, we infected hippocampal neurons with control or CST-TKD viruses at DIV3 and measured neuron soma size during cultured neuron development every other day from DIV5 to DIV13 ( Figure S6 ). We observed that the soma size of cultured neurons infected with control viruses abruptly increased between DIV7 and DIV9, whereas no increase in the soma size of neurons infected with CST-TKD was observed ( Figure S6 ), suggesting that a deficiency of CST proteins arrests neuronal development, which manifests as an absence of growth in the cell-body size. In contrast, the soma size of neurons transfected with CST-TKD was unchanged ( Figure S4D ), indicating that the effects of CSTs in regulating neuronal soma size were non-cell autonomous. Because the simultaneous KD of multiple proteins occasionally leads to confounding, nonspecific phenotypes, we further examined whether the decreases in soma size and synapse number induced by CST-TKD could be rescued through the coexpression of shRNA-resistant CSTs (Figures 4G-4I ). We observed that superinfection with both CST-1 and CST-3 completely eliminated the deficits in both soma size and synapse density observed with CST-TKD ( Figures 4G-4I) . Strikingly, the superinfection of either CST-1 or CST-3 alone did not restore the deficits in soma size but did restore the deficits in synapse number, suggesting that all three CSTs contribute to the growth of the neuronal cell body in a concerted manner. We also noted that the lentiviral expression of CST-1, CST-2, or CST-3 alone did not affect synapse density ( Figure 4H ). Thus, we considered whether our lentiviral expression system yielded lower expression levels of CSTs than chemical transfection. We compared the effect of expressing CST-3 in cultured hippocampal neurons using a CST-3 lentiviral construct with CST-3 expression plasmid transfection using a Ca 2+ -phosphate/DNA coprecipitation method ( Figures S7A-S7C ). The overexpression of CST-3 by chemical transfection significantly increased the synapse density, whereas lentiviral CST-3 expression did not, implying that the CST-3 expression level per se is critical for synapse maintenance ( Figures S7A-S7C ). Using the CST-3 wild-type (WT) expression vector, we found that CST-3 WT exerted synaptogenic activities in gainof-function assays. CSTs are cleaved by a-secretases (Maruta et al., 2012) , raising questions concerning the expression of these 
Expressions of CSTs in Mouse Brains
(A) CST mRNA distribution patterns in the developing and adult mouse brains. Sections from E16, E18, P7, P14, P21, and P48 (adult) mouse brains were probed with CST-1, CST-2, and CST-3 cRNAs. The scale bar represents 5 mm. Cb, cerebellum; Ctx, cerebral cortex; Hc, hippocampus; OB, olfactory bulb. (B) Biochemical characterization of the CST antibodies used in this study. Immunoblot analyses of CST antibodies using mouse-brain synaptosomes and lysates from HEK293T cells, untransfected or transfected with CST-2 or CST-3 expression vector. JK010 is reactive to both CST-1 and CST-2 proteins, whereas JK001 is specific to CST-3. Br, brain; P2, crude synaptosomes; Unt, untransfected HEK293T cell lysates. (C) Cross-reactivity of the CST antibodies. HEK293T cells, untransfected or transfected with the indicated CST expression vectors, were immunoblotted with CST-1/CST-2 (JK010) and CST-3 (JK001) antibodies. The expression of HA-tagged CST vectors was confirmed through immunoblotting with HA antibodies. An a-tubulin antibody was used for normalization.
(legend continued on next page)
CST constructs on the surface of heterologous cells and neurons. We found that, although the majority of CSTs are secreted into the cell-culture medium, 10%-35% of CSTs are expressed on the surface of both HEK293T cells and cultured neurons (Figures  S7D-S7G ; data not shown), suggesting that surface-exposed CSTs remain competent.
KD of CSTs Leads to a Reduction in Inhibitory, but Not Excitatory, Synaptic Transmission In Vitro and In Vivo To determine whether the changes in anatomical synapse numbers presented in Figure 4 reflect changes in the number of functional synapses, we examined synaptic transmission in mouse cultured hippocampal neurons infected with control or CST-TKD viruses ( Figures S5C-S5H) . Strikingly, measurements of miniature excitatory postsynaptic currents (mEPSCs) showed that CST-TKD did not alter excitatory synaptic transmission (Figures S5C, S5E, and S5F) . In contrast, CST-TKD caused a significant decrease in the frequency, but not the amplitude, of miniature inhibitory postsynaptic currents (mIPSCs) (Figures S5D, S5G, and S5H) . These results suggest that, although CSTs are required for the maintenance of both excitatory and inhibitory synapses, these molecules are predominantly involved in regulating inhibitory synaptic functions.
To further corroborate the in vitro electrophysiological results, we examined the effect of CSTs KD in somatosensory cortical layer II/III neurons in vivo through the in utero electroporation at E15 and analysis at P14-P19 ( Figure 5A ). Similar to the results obtained with cultured neurons, CST-TKD specifically reduced the frequency of mIPSCs ( Figures 5B-5D ) without altering the frequency or amplitude of mEPSCs (Figures 5E-5G). Unexpectedly, CST-TKD increased the amplitude of mIPSCs. The explanation for this observation is not clear but might reflect the decreased soma size of CST-deficient neurons or increased gephyrin puncta intensity (see Figures 4, 5J, and 5K; data not shown). We detected no changes in the paired-pulse ratio (PPR) of inhibitory IPSCs in CST-TKD neurons, indicating no effects on presynaptic functions (Figures 5H and 5I) . Consistent with the cultured neuron morphology, the soma sizes of CST-TKD neurons were smaller, as demonstrated by a decrease in membrane capacitance and a trend toward increased input resistance (Figures 5J and 5K) . Taken together, these results indicate that CSTs are required for inhibitory synaptic transmission in vitro and in vivo.
CST-3 Forms Functional Complexes with Nrxs to Induce Presynapse Development
CSTs contain two extracellular cadherin repeats and an LNS domain, and CST-3 displays synaptogenic activity, inducing presynaptic differentiation in heterologous synapse-formation assays (Figures 1 and 2 ). To identify proteins that interact with the extracellular regions of CST-3, we used affinity chromatography, employing recombinant CST-3 fusion proteins expressed from HEK293T cells transfected with immunoglobulin (Ig)-CST-3 comprising the entire extracellular sequence of CST-3 fused to the Fc-domain of human IgG to probe solubilized mouse brains ( Figure 6A ). Mass spectrometry analyses of Coomassie-bluestained gels revealed multiple bands that were not observed in the negative control lane (IgC; Figure 6B ). Among the identified peptides, multiple peptides were derived from cell-surface proteins, such as Nrxs (Figures 6C-6F ; Tables 1 and S2 ). We asked whether Nrxs are required for the synaptogenic activities of CST-3. We infected cultured neurons with lentiviruses expressing either an empty shRNA vector (control) or a triple-KD shRNA construct for Nrxs (Nrx-TKD). Subsequently, we performed heterologous synapse-formation assays using infected neurons and HEK293T cells expressing CST-3, NL1 (positive control), or Slitrk1 (negative control) (Figures 6G and 6H) . Upon Nrx-TKD, we observed the absence of CST-3-induced synapsin clustering on contacting axons of cocultured hippocampal neurons. In parallel experiments, Nrx-TKD abolished the synaptogenic activities of NL1, but not those of Slitrk1, consistent with the notion that Nrxs are presynaptic receptors for NL1 (note that PTPd and PTPs are presynaptic ligands for Slitrk1; see Gokce and Sü dhof (2013) and Yim et al. (2013) . Taken together, these results indicate that CST-3 forms a functional complex with Nrxs.
CST-3 Does Not Directly Interact with Nrxs
The fact that presynaptic Nrxs are functional receptors for CST-3 ( Figure 6 ) prompted us to examine whether Nrxs directly bind to CST-3. First, we employed cell-surface-labeling assays to determine whether CST-3 directly binds to both a-and b-Nrxs ( Figures 7A and 7B ). We examined the binding of recombinant Ig-fusion proteins of Nrx-1a and -1b lacking an insert in splice site (SS) no. 4 (Ig-Nrx1a SS4À and Ig-Nrx1b
SS4À
, respectively) to HEK293T cells expressing hemagglutinin (HA)-tagged CSTs. Surprisingly, we observed no binding of the Ig-Nrx1 fusion proteins with HA-CSTs in cell-surface-labeling assays ( Figure 7A ). Consistent with this observation, we found that the Ig-CST-3 fusion protein did not bind FLAG-tagged Nrxs in cell-surfacelabeling assays ( Figure 7B ). There are three alternative splicing sites unique to a-Nrxs (Ullrich et al., 1995); thus, we hypothesized that the presence of inserts at any or all of these sites (SS no. 1, SS no. 2, and SS no. 3) might modulate the binding between CST-3 and a-Nrxs in a combinatorial manner. To examine this hypothesis, we generated a series of Nrx-1a constructs containing a subset of domains with selected splice variants (see Figure 7C for schematic diagrams of HA-Nrx-1a constructs) and analyzed the binding of these proteins to recombinant CST-3 using cell-surface-labeling assays ( Figure 7D ). Strikingly, any Nrx1a variants showed no robust binding to HA-CST-3, indicating that Nrx-1a is not a direct ligand for CST-3. Moreover, neither Nrx-2a nor Nrx-3a interacted with CST-3 in (D) Authenticity of the CST-3 antibody (JK001). P2 fractions from brains of wild-type or CST-3-KO mice were subjected to immunoblot analyses with the indicated antibodies. An a-tubulin antibody was used for normalization. (E) The expression of CST proteins during development. E, embryonic day; P, postnatal day. An a-tubulin antibody was used for normalization. (F) Localization of CST proteins in PSD fractions. The proteins from each mouse brain fraction (5 mg) were subjected to immunoblotting with the indicated antibodies. P2, crude synaptosomal fraction; S2, cytosolic and light membrane fraction; PSD, postsynaptic density fraction; SynPhys, synaptophysin; Synapto. Fraction, Synaptosomal fraction.
cell-surface-labeling assays ( Figure 7D ). Consistently, we found that CST-3 Cad did not bind to Nrx1a, suggesting that CST-3 exerts synaptogenic activity through a mechanism independent of direct binding to Nrxs ( Figure 7A ). Furthermore, pull-down experiments using immobilized Nrx-1a and Nrx-1b (Ig-Nrx1a SS4À and Ig-Nrx-1b
) Ig-fusion proteins with mouse synaptosomal fractions revealed that both Ig-Nrx-1a SS4À and
Ig-Nrx-1b SS4À effectively captured NL1, but did not bind to CSTs ( Figure 7E ), supporting the absence of an interaction of Nrx with CSTs. Viewed together, these results suggest that (C) Measurements of target mRNA levels (CST-1, CST-2, and CST-3) in cultured cortical neurons as described in (B), except that neurons were infected with CST-TKD lentiviruses expressing shRNAs targeting CST-1, CST-2, and CST-3 (described in A). The target mRNA measured is color coded as indicated on the upper right. Dotted line represents the 75% KD cutoff level for tests of biological effects. (D) Representative images of cultured hippocampal neurons infected at DIV3 with lentiviruses expressing EGFP alone (control); coexpressing EGFP with shRNAs against CST-1, CST-2, and CST-3 (CST-TKD); or coexpressing EGFP with shRNAs against LRRTM1 and LRRTM2 (LRRTM-DKD). Neurons were analyzed through double immunofluorescence labeling for MAP2 (blue) and synapsin (red) at DIV14. The scale bar represents 35 mm (applies to all images). (E and F) Summary graphs of the effects of CST-TKD in neurons on synapse density (E; measured using synapsin as a general synapse marker, VGLUT1 as an excitatory presynaptic marker, GAD67 as an inhibitory presynaptic marker, Homer1 as an excitatory postsynaptic marker, and gephyrin as an inhibitory postsynaptic marker) and soma size (F; measured using MAP2 signals). The data are shown as the means ± SEMs ( 3 *p < 0.001, assessed using ANOVA with Tukey's test; 2 to 3 dendrites per transfected neuron were analyzed and group averaged; n denotes the total number of neurons analyzed, as follows: control/synapsin, n = 16; CST-TKD/synapsin, n = 18; LRRTM-DKD/synapsin, n = 15; control/VGLUT1, n = 15; CST-TKD/VGLUT1, n = 15; control/GAD67, n = 16; CST-TKD/GAD67, n = 15; control/Homer1, n = 18; CST-TKD/Homer1, n = 21; control/gephyrin, n = 22; and CST-TKD/gephyrin, n = 22). (G) Representative images of cultured hippocampal neurons infected with a vector expressing control lentiviruses (control); a vector expressing shRNA viruses against CST-1, CST-2, and CST-3 (CST-TKD); the CST-TKD vector together with lentiviruses expressing full-length human CST-1 (denoted as Rescue [+CST-1]), full-length human CST-3 (denoted as Rescue [+CST-3]), or both human CST-1 and human CST-3 (denoted as Rescue [+CST-1/3]); or lentiviruses expressing only full-length human CST-1 (CST-1), full-length human CST-2 (CST-2), or full-length human CST-3 (CST-3). The neurons were analyzed through double immunofluorescence using antibodies to MAP2 (blue) and synapsin (red) at DIV14. The scale bar represents 35 mm (applies to all images). (H and I) Summary graphs of the effects of the indicated lentiviruses on synapse density (H; measured using synapsin as a general synapse marker) and soma size (I; measured using MAP2 signals). Note that lentiviral expression of CST-3 did not increase synapse density, whereas high-level overexpression of CST-3 by calcium-phosphate-mediated transfection significantly increased the synapse density (see Figure S7) . The data are shown as the means ± SEMs ( 3 *p < 0.001; assessed using ANOVA with Tukey's test; 2 to 3 dendrites per transfected neuron were analyzed and group averaged; n denotes the total number of neurons analyzed, as follows: control, n = 19; CST-TKD, n = 14; CST-TKD+CST-1 rescue, n = 15; CST-TKD+CST-2 rescue, n = 16; CST-TKD+CST-3 rescue, n = 17; CST-TKD+CST-1/3 rescue, n = 16; CST-1, n = 15; CST-2, n = 22; and CST-3, n = 17).
CST-3 requires Nrxs for its presynapse-inducing activities but is indirectly linked to them.
DISCUSSION
Currently, the neural roles of CST-1 have been extensively studied in the brain, showing that CST-1 is localized to both excitatory and inhibitory synapses and forms a tripartite complex with both Mint/X11 adaptor protein and APP, stabilizing intracellular APP metabolism and thereby suppressing Mint/X11-mediated Ab secretion (Araki et al., 2003; Vogt et al., 2001) . Moreover, CST-1 mediates the transport of axonal APP-containing organelles in a kinesin-1-dependent manner (Konecna et al., 2006; Vagnoni et al., 2011 Vagnoni et al., , 2012 . Recently, several genetic studies have implicated CST-2 polymorphisms in episodic memory performance, suggesting that CST-2 might regulate cognitive processes in the brain (Papassotiropoulos et al., 2006; Preuschhof et al., 2010) . However, the synaptic functions of CST proteins have not been investigated. Particularly, the functions of CST-3 have been less explored than those of CST-1 and CST-2. The cadherin superfamily proteins are key regulators of various neuronal processes but have been generally considered dispensable for de novo synapse formation (Scheiffele et al., 2000; Takeichi, 2007) . Instead, these proteins have been suggested as critical for modulating numerous synaptic signaling pathways and synaptic plasticity (Arikkath and Reichardt, 2008) . Here, we demonstrated that the two cadherin repeats of CST-3 are required for the synaptogenic activity of this protein (Figure 2 ). However, it was recently reported that the cadherin repeats of CST-3 are required, but not sufficient, for the synaptogenic activity of CST-3 (Pettem et al., 2013) , inconsistent with the results obtained in the present study. Although the nature of this discrepancy is currently unclear, the surface expression levels of the plasmids used in these two studies might differ, leading to completely different conclusions. Moreover, the fact that CSTs possess only two cadherin repeats at the N terminus is a striking exception in the cadherin superfamily, as the majority of cadherin proteins possess five or more repeats (Hulpiau and van Roy, 2009 ). Furthermore, CST-TKD halted neuron growth, resulting in smaller soma size (Figures 4 and S6) . Although the roles of cadherin superfamily proteins in neuron development have been relatively well established, this study reports that members of this family are directly involved in the neuron soma development. Importantly, CSTs are among represent the means ± SEMs (*p < 0.05 using Student's t test; n denotes the total number of cells recorded, as follows: mIPSC control, n = 10; mIPSC CST-TKD, n = 12; mEPSC control, n = 29; mEPSC CST-TKD, n = 30; PPR control, n = 13; and PPR CST-TKD, n = 15).
a small group of evolutionarily conserved synapse organizers, including NLs, Nrxs, and leukocyte antigen-related receptor protein tyrosine phosphatases. In invertebrates, these synapse organizers have been implicated in neuron development and synaptic functions (Calahorro and Ruiz-Rubio, 2013; Hu et al., 2012) . CASY-1, the C. elegans ortholog of CSTs, is also essential for associative learning (Hoerndli et al., 2009; Ikeda et al., 2008) ; the Drosophila ortholog of CSTs (Cals) has not yet been using ANOVA with Tukey's test; n denotes the total number of HEK293T cells analyzed, as follows: control/sh-control, n = 19; control/sh-Nrx1/sh-Nrx2/sh-Nrx3, n = 45; CST-3/sh-control, n = 43; CST-3/sh-Nrx1/sh-Nrx2/sh-Nrx3, n = 39; NL1/sh-control, n = 30; NL1/sh-Nrx1/sh-Nrx2/sh-Nrx3, n = 28; Slitrk1/sh-control, n = 24; and Slitrk1/sh-Nrx1/sh-Nrx2/sh-Nrx3, n = 29).
functionally explored. Because the neuronal expression of human CST-2 in C. elegans functionally rescues the learning defects of CASY-1 mutants, we also examined whether Cals is synaptogenic using heterologous synapse-formation assays. However, Cals proteins, like CST-1 or CST-2, did not induce presynaptic differentiation (data not shown). Thus, whether the functional significance of the Nrx/CST interaction reported in the present study also applies to the other model organisms remains undetermined. Nrxs are essential for synapse formation and function (reviewed in Kang, 2007 and Sü dhof, 2008) . The coupling of calcium channels to presynaptic machinery in mouse genetics studies has shown that a-Nrxs are important for presynaptic functions, but not structural integrity (Dudanova et al., 2007; Missler et al., 2003) . The loss of all three a-Nrxs dramatically reduces spontaneous and evoked synaptic transmission at both excitatory and inhibitory synapses, although the defect in excitatory synaptic transmission reflects an Nrx-a1 deficiency Missler et al., 2003) . a-Nrxs transsynaptically interacts with a multitude of postsynaptic adhesion molecules, including NLs, LRRTMs, cerebellins, dystroglycans, latrophilins, and neurexophilins (reviewed in Krueger et al., 2012) . However, because most of these postsynaptic ligands interact with both a-and b-Nrxs (except neurexophilins), the functions of these synaptic adhesion pathways cannot be exclusively attributed to a-Nrx-specific synaptic functions. The data obtained in the present study suggest that CST-3 does not form a physical complex with Nrxs but requires interactions with these molecules for synaptogenic activities, suggesting unidentified ''intermediary'' proteins that bridge CST-3 and Nrxs. A recent study reported that a-Nrxs, but not b-Nrxs, directly interact with CST-3 (Pettem et al., 2013) . These authors presented a series of cell-surface-labeling and pull-down assays to demonstrate the interaction of CST-3 with a-Nrxs. However, we did not observe any significant binding of CST-3 to any of the three a-Nrxs in cell-surface-labeling assays (Figure 7) . Moreover, we found that various deletion variants of Nrx-1a did not interact with CST-3. Furthermore, we did not observe any significant enrichment of CSTs with recombinant Nrx-1a proteins in mouse brain pull-down assays (Figure 7) . Overall, we found no clear-cut evidence to support the direct interaction of CST-3 with a-Nrxs. Nevertheless, we observed that Nrxs are essential for CST-3 function because the triple knockdown of Nrxs significantly reduced the synaptogenic activities of CST-3 ( Figure 6 ). Currently, there is no precise explanation for the discrepant results between the two papers. Indeed, our data present two inherent paradoxes that we cannot at present resolve but that paint a very different picture than that proposed by Pettem et al. (2013) . First, in artificial synapse-formation assays, only CST-3 is active, but not the other CSTs, whereas only a combined triple knockdown of all CSTs affects synapse density. Second, in pull-downs with recombinant CST-3, some Nrxs were found, and in artificial synapse-formation assays, the presynaptic Nrx-TKD blocked CST-3-induced synapse formation, but in all other binding assays, no CST-3 binding to Nrxs was detected. Most of these data were obtained in our laboratories before Pettem et al. (2013) was published, but we did not proceed to publication because we could not rationally reconcile these results and formulate a coherent conclusion from them. We do feel, however, that based on our observations, it is highly unlikely that CSTs are general Nrx ligands analogous to LRRTMs, neuroligins, or cerebellins.
In the present study, we found that the suppression of multiple CST isoforms, but not individual CSTs, reduced synapse density, suggesting redundancy among CST isoforms (Figure 4) . However, electrophysiology experiments in both cultured and in vivo neurons indicated that CSTs act preferentially to inhibitory synapse structure and function (Figures 5 and S5 ). These results are consistent with those from previous reports, showing that triple-NL loss through acute KD in cultured neurons suppresses the frequency of mIPSCs (Chih et al., 2005) . Moreover, a-Nrxspecific sequences confer specific activity toward inhibitory synapses in heterologous synapse-formation assays (Kang et al., 2008) , suggesting that CST-3 might be a major postsynaptic mediator of inhibitory synapse organization through a-Nrxs. Notably, although CST-3 KD alone did not significantly affect synapse density in cultured neurons (Figure 4) , synaptic transmission might be impaired at specific synapses, as demonstrated for individual NL isoforms (Chubykin et al., 2007) . Consistently, analyses of CST-3-KO mice showed that both excitatory and inhibitory synaptic transmissions are impaired (Pettem et al., 2013) .
Although certain mechanistic details remain unresolved, CSTs have been predominantly associated with AD pathogenesis (reviewed in Suzuki et al., 2006) . For example, CST-1 modulates the effects of APP processing and trafficking, and CSTs coaccumulate with APP in dystrophic neuritis. Moreover, CST-1 KD perturbs the axonal transport of APP-containing vesicles and alters APP processing, leading to increased Ab production (Vagnoni et al., 2012) . Furthermore, the proteolytically processed C-terminal fragment of CST-3 accumulates in dystrophic neurites surrounding Ab plaques in AD model mice, accelerating neuronal death (Uchida et al., 2013) . Intriguingly, CST-1 and CST-3 have been identified as potential biomarkers of AD (Ringman et al., 2012; Yin et al., 2009) . Recently, several g-secretase mutations impair Nrx-3b processing, linking Nrxs with AD pathogenesis (Bot et al., 2011) . It is tempting to speculate that the misregulation of CST-3 and/or Nrx proteolytic processing might induce a subset of early onset familial AD. It has been suggested that an imbalance between excitatory and inhibitory synapses is the central mechanism underlying a multitude of neuropsychiatric disorders. In the present study, we observed that inhibitory synapse function is selectively disrupted through CST-TKD in both cultured and in vivo neurons. Although there are currently no reports that CSTs are involved in neuropsychiatric disorders, it is likely that the synaptic dysfunction of CSTs contributes 
(legend continued on next page)
to the pathogenesis of multiple neuropsychiatric disorders. Intriguingly, CST-1 mRNA levels are upregulated in chronic cocaine-treated mice, suggesting that CST-1 dysfunction might be associated with addiction (Yao et al., 2004 ) via impaired long-term synaptic plasticity at inhibitory synapses (Niehaus et al., 2010) . Some neuropsychiatric disorders (e.g., schizophrenia, autism, and intellectual disabilities) have been associated with specific defects in the development and function of interneurons. Considering that CST-2 and CST-3 are highly expressed in interneurons (Hintsch et al., 2002) , it is possible that the molecular dysfunctions of these CST isoforms contribute to these diseases.
In conclusion, we identified CST-3 as a synaptogenic adhesion molecule that forms complexes with Nrxs. Future studies should identify intermediary protein(s) that functionally bridge CST-3 and Nrxs, characterize the detailed molecular mechanisms underlying the intracellular transduction of CST-3/Nrxs extracellular signals, identify the presynaptic receptors for CST-1 and/or CST-2 to establish a complete understanding of the synaptic functions of CST proteins, and validate the functions of CSTs proposed in the current study in vivo.
EXPERIMENTAL PROCEDURES
The Construction of Expression Vectors HA-CSTs encode full-length mouse CSTs containing an inserted HA-epitope. The signal peptide sequence of CST-1 (amino acids [aa] 1-28) was initially PCR amplified, digested with HindIII/BglII, and cloned into the GW1 vector (British Biotechnology). The remaining CST-1 sequences (aa 29-979) were PCR amplified, digested with BglII and EcoRI, and cloned into the GW1 vector. Full-length CST-2 and CST-3, excluding the corresponding signal peptide sequences (CST-2, aa 21-966; CST-3, aa 20-956), were PCR amplified, digested with XmaI and SacII, and subcloned into the pDisplay vector (Invitrogen). pDis-CST-3 deletion variants encode the indicated CST-3 fragment (Cad+LNS, aa 36-541; LNS+linker, aa 335-846; Cad repeats, aa 20-257; LNS, aa 335-541; Cad repeat 1, aa 36-158; and Cad repeat 2, aa 152-259) cloned into the pDisplay vector at XmaI and SacII sites. pDis-Nrxs encode the indicated Nrx-1a, Nrx-1b, Nrx-2a, or Nrx-3a fragments cloned into the pDisplay vector at the indicated restriction enzyme sites. To construct shRNA lentiviral expression vectors, oligonucleotides targeting mouse CST-1, CST-2, or CST-3 were annealed, phosphorylated, and cloned into the XhoI and XbaI sites of a single KD vector (L-309 vector; see Figure 4A for a schematic diagram of vectors) immediately downstream of the human H1 promoter. For CST-TKD, oligonucleotides targeting CST-1 (J73), CST-2 (J76), and CST-3 (J81) were subcloned, respectively, into the XhoI-XbaI (J73), BstEIIBsiWI (J76), and SbfI-BstBI (J81) sites of a TKD vector (L-313 vector) containing two human H1 promoters and two human U6 promoters. For the details, see the Supplemental Experimental Procedures.
Antibodies
Antibodies used in this study are described in detail in the Supplemental Information associated with this paper.
Heterologous Synapse-formation Assays, Cell Surface-Labeling Assays, and Cell-Adhesion Assays Heterologous synapse-formation assays, cell-surface-labeling assays, and cell-adhesion assays were performed using HEK293T cells as previously described (Ko et al., 2009a) .
Affinity Chromatography and Mass Spectroscopy
Affinity chromatography and mass spectroscopy were performed using recombinant CST-3 fusion proteins as previously described (Ko et al., 2009a) .
Production of Recombinant Lentiviruses
Recombinant lentiviruses were produced through the transfection of human embryonic kidney 293T cells with four plasmids-L-313 vectors (L-313-Nrx-TKD or L-313 alone), pRRE, pVSVg, and pREV-using FuGENE-6 (Roche) as previously described .
Primary Neuronal Culture, Transfections, Immunocytochemistry, Image Acquisition, and Analyses Primary neuronal culture, transfections, immunohistochemistry, image acquisition, and analyses were performed using E18-derived mouse hippocampal cultured neurons and confocal microscopy as previously described (Ko et al., 2009b) .
In Utero Electroporation
Pregnant ICR mice at 15 days post coitum were anesthetized with an intraperitoneal injection of pentobarbital sodium, and the uterine horns were exposed through a longitudinal incision in the abdomen. Approximately 1 ml of DNA solution containing 1 mg/ml pCAGGS-EGFP, 1.5 mg/ml L-315-CST-TKD shRNA, and 0.01% Fast Green in PBS or 1 mg/ml pCAGGS-EGFP, 1.5 mg/ml L-315 control shRNA, and 0.01% Fast Green in PBS was injected into the lateral ventricle of each embryo through a glass capillary electrode. The uteri were returned to the peritoneal cavity, and the incisions were sutured. The operated mice were returned to their home cages and subsequently allowed to deliver naturally. The transfected pups were identified at P 0 by visualizing the GFP signals through the scalp using a light-emitting diode penlight (Handy Blue; Reryon).
Electrophysiology
Cell culture and slice electrophysiology were performed as previously described .
Statistics
All data are expressed as the means ± SEM. All experiments were performed with at least three independent cultures and statistically evaluated using Student's t test and one-way ANOVA, with cell numbers as the basis for ''n''.
Further details are available in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, seven figures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.celrep.2014.02.010.
(C) Domain structures of a-and b-Nrxs (top) and identities of pDisplay-Nrx constructs used for binding studies (bottom). SP, signal peptide; LNS, lamin G-domain repeats, neurexins, and sex hormone-binding globulin; E, EGF-like sequences; CHO, carbohydrate attachment site; T, transmembrane region; blue numbered arrows, positions of canonical alternative splice sites (Ullrich et al., 1995) . ''À'' corresponds to the no-insert variant; ''+'' corresponds to the small insert; and ''++'' corresponds to the large insert (see Sugita et al., 2001) . N.A., not applicable. (D) Cell-surface-labeling assays. HEK293T cells expressing pDis-Nrx-a constructs were incubated with control Ig or Ig-CST-3. The cells were analyzed by immunofluorescence imaging for Ig-fusion proteins (red) and HA (green). Representative merged images are shown. The scale bar represents 10 mm (applies to all images).
(E) Pull-down assays in solubilized mouse synaptosomal fractions. The pull-down assays were performed using IgC (control), IgNrx-1a-1, or IgNrx-1b-1 recombinant proteins. Equivalent amounts of bound proteins were analyzed using the antibodies indicated on the right side of the panels (input = 5% of total). 
Supplemental Information Calsyntenins Function as Synaptogenic Adhesion Molecules in

Concert with Neurexins
Ji Won Um Table S1 . Candidate molecules expressed in HEK293T cells that were screened for induction of presynaptic differentiation in heterologous synapse-formation assays. Table S2 . Detailed list of peptides indicating that neurexin-α proteins as the specific binding proteins of CST-3. Nrx1α-1, aa 15-1361; Nrx-1α-18, aa 15-207; Nrx-1α-21, aa 298-506; Nrx-1α-24, aa 298-506; Nrx-1α-25, aa 298-506; Nrx-1α-31, aa 920-1361; Nrx-1α-32, aa 920-1361; Nrx-1α-37, aa 738-931; Nrx-1α-38, aa 738-931; Nrx-1α-39, aa 486-931; Nrx-1α-40, aa 486-931; Nrx-1α-41, aa 15-1361; Nrx-1β-1, aa 15-299; Nrx-2α, aa 29-1628; and Nrx-3α, aa 28-1513) cloned into the pDisplay vector at XmaI and SacII sites , BglII and SalI sites . To CST-3 was subcloned into the L-313 vector at the NheI and BsrGI sites. The following constructs were previously described: pCMV5-NL1-mVenus ; pCMV5-NL2-mVenus ; pCMV5-IgC-NL2 ; L315-LRRTM-DKD ; L-315-Nrx-TKD (Zhang et al., 2010) ; pDis-HA-Slitrk1 (Yim et al., 2013) ; pCMV-IgCNrx-1α-1 and pCMV-IgC-Nrx-1β-1 (Boucard et al., 2005) . pcDNA3.1-CST-1, pcDNA3.1-CST-2, and pcDNA3.1-CST-3 were gifts from Peter Sonderegger (Univ. of Zurich, Switzerland (Hintsch et al., 2002) ).
Genes Expression Vector
Extended Experimental Procedures
Antibodies. CST-3 peptides (JK001; CSDERRIIESPPHRY) were synthesized and conjugated to keyhole limpet hemocyanin through a cysteine added to the N-terminus of the peptide. Glutathione-S-transferase (GST) fusion proteins encoding mouse CST-2 (JK010; aa 818-912) were produced in BL21 E. coli and purified on a glutathione-Sepharose column (GE Healthcare). Following the immunization of rabbits with these immunogens, the specific antibodies were affinity-purified using a Sulfolink column (Pierce) Rabbit polyclonal anti-Homer1 (1133; a gift from Eunjoon Kim) was previously described (Sala et al., 2001) .
Heterologous Synapse-formation Assays. Heterologous synapse-formation assays were performed using HEK293T cells as described previously (Yim et al., 2013) . Briefly, HEK293T cells were transfected with EGFP (negative control), pCMV-5-NL1-mVenus (positive control), or various CST expression vectors as indicated (described in "Construction of Expression
Vectors") using FuGene6 (Roche). After 48 h, the transfected HEK293T cells were trypsinized, seeded onto hippocampal neuron cultures at DIV8-10, cocultured for an additional 72 h, and double-immunostained at DIV11-13 with antibodies against GFP or HA (to detect various CST expression vectors containing an HA epitope) and synapsin I, VGLUT1, GAD67, or PSD-95, as previously described (Ko et al., 2009 ). All images were acquired using a confocal microscope. For quantification, the contours of the transfected HEK293T cells were chosen as the region of interest. The fluorescence intensity of synapsin puncta normalized to each HEK293T cell area was quantified for both red and green channels using MetaMorph Software (Molecular Devices).
Cell-surface Labeling Assays. Fc-fusion proteins of deletions and NL2 were produced from HEK293T cells. Soluble Fc-fused proteins were purified using protein A-Sepharose beads (GE Healthcare). The bound proteins were eluted with 0.1 M glycine (pH 2.5) and immediately neutralized with 1 M Tris-HCl (pH 8.0).
Transfected HEK293T cells expressing pDisplay-Nrx variants were incubated with 0.2 μM Fc or CST-3-Fc as indicated in Figure 7 . The images were acquired using a confocal microscope (LSM510; Zeiss).
Cell-adhesion Assays. Cell-adhesion assays were performed using L cells, as previously described (Ko et al., 2009) . Briefly, L cells were transfected with individual expression vectors, as indicated. After 48 h, the cells were detached, mixed, and incubated at room temperature with gentle agitation. The extent of cell aggregation was measured at 2 h, spotting cell aliquots onto four-well culture slides, and imaging with confocal microscopy. For quantitation of the cell number per cluster, the cell clusters were defined as cell aggregates containing four or more cells that included at least one green (EGFP) and one red (DsRed) cell. Frames with no detectable cell clusters were counted as zero.
Affinity Chromatography. The brains from ten 6-week-old rats were homogenized in buffer [50 mM HEPES (pH 7.4), 50 mM NaCl, 2 mM CaCl 2 , 2 mM MgCl 2 , and protease inhibitors], extracted with 1% Triton X-100 for 1 h at 4°C, and centrifuged at 32,000 x g for 1 h at 4°C to pellet insoluble materials. Protein A-Sepharose beads (GE Healthcare), prebound to 100 μg of IgC-CST-3 or IgC protein, were added to the supernatant and rotated overnight at 4°C. The HPLC chip was incorporated onto an enrichment column (9 mm, 75 μm I.D., 160 nl) and reverse-phase column (15 cm, 75 μm I.D., packed with Zorbax 300SB-C18 5 μm resins).
The peptide separation was performed using a 110min gradient of 3-45% buffer B (buffer A containing 0.1% FA and buffer B containing 90% ACN/0.1% FA) at a flow rate of 300 nl/min.
The MS and MS/MS data were acquired in the positive ion mode, and the data were stored in the centroid mode. The chip spray voltage was set at 1850 V and carried with chip conditions. The drying gas temperature was set at 325 with a flow rate of 3.5 L/min. A medium isolation (4 m/z) window was used for precursor isolation. Collision energy with slope of 3.7 V/100Da and offset of 2.5 V was used for fragmentation. The MS data were acquired over a mass range of 300-3000 m/z, and the MS/MS data were acquired over a mass range of 50-2500 m/z. The reference mass correction was activated using a reference mass of 922. The precursors were set in an exclusion list for 0.5 min after two MS/MS spectra. The MS/MS spectra were extracted using the MassHunterQualitative Analysis B.05.00 software (Agilent Technologies, Santa Clara, CA) with default parameters, and the spectra were interpreted using Mascot v2.3 (Matrix Science, London, UK) to search against the Uniprot/Swiss-Prot database (10/5/2012). Individual ion scores >23 indicated identity or extensive homology (p value < 0.05). The database searches were performed with a peptide mass tolerance of 10 ppm, a MS/MS tolerance of 0.5 Da, and a strict tryptic specificity that allowed one missed cleavage site. The carbamidomethylation of Cys was set as a fixed modification, whereas oxidation (M) was considered a variable modification.
In Situ Hybridization. In situ hybridization probes were constructed into pGEM7zf hybridization was performed as previously described (Ko et al., 2006; Lee et al., 2013) .
Briefly, riboprobes were transcribed in the presence of 35 S-UTP (Amersham), and subsequently the labeled probes were hybridized with mouse brain sections (as indicated in Figure 3A ) overnight at 52°C. The next day, the mouse brain sections were treated with RNase A (Boehringer-Manheim) for 30 min at 37°C, washed, dehydrated with ethanol, and air-dried. The hybridized radioactivity for CSTs was visualized through exposure to Biomax film (Kodak).
Preparation of the Postsynaptic Density Fraction. The PSD fraction was prepared as previously described (Dosemeci et al., 2006) . Briefly, the mouse brains were homogenized in 0.32 M sucrose/1 mM MgCl 2 solution containing protease inhibitor cocktail (Thermo Scientific) using a Teflon/glass homogenizer. The homogenates were transferred to microfuge tubes and centrifuged at 470 x g for 2 min using a fixed-angle rotor. The resultant supernatant was decanted into a fresh microfuge tube and centrifuged at 10,000 x g for 10 min using the same rotor to obtain a mitochondria-and synaptosome-enriched pellet (P2).
The (P2) pellet was resuspended in 0.32 M sucrose, and the suspension was layered onto 750 l of 0.8 M sucrose in a microfuge tube. The samples were centrifuged 9100 x g for 15 min using a swinging bucket rotor. Following centrifugation, the myelin/light membrane layer at the 0.32/0.8 M sucrose interface was removed, and the 0.8 M sucrose layer, and most of the loose pellet containing the synaptosomes were collected, leaving the harder mitochondrial pellet. In subsequent experiments, the centrifugation step was shortened to 10 min to minimize the pelleting of synaptosomes. The collected synaptosomes in 0.8 M sucrose were diluted with 20 mM HEPES (pH 7) to obtain a final sucrose concentration of 0.4 M. An equal volume of 2% Triton X-100/150 mM KCl solution was added, and the samples were rotated in the cold for 15 min, followed by centrifugation at 20,800 x g for 45 min using a fixed-angle rotor. The pellets were resuspended in a 1% Triton X-100/75 mM KCl solution using a mini dounce homogenizer and centrifuged at 20,800 x g for 30 min using the same rotor. The pellets were resuspended in 20 mM HEPES and centrifuged as described above. For immunoblotting, the nitrocellulose membranes were incubated with antibodies against CST-2 (JK010; 1:1000), CST-3 (JK001; 1:1000), PSD-93 (NeuroMab; 1:1000), and synaptophysin (Sigma; 1:3000).
Production of Recombinant Lentiviruses. To generate the recombinant lentiviruses, human embryonic kidney 293T cells were transfected with four plasmids-L-313 vectors (L-313-Nrx-TKD or L-313 alone), pRRE, pVSVg, and pREV-using FuGENE-6 (Roche), as previously described .
Primary Neuronal Culture, Transfections, Immunocytochemistry, Image Acquisition and Analyses. E18 embryos were used to prepare hippocampal or cortical cultures, as previously described (Ko et al., 2003; . For immunocytochemistry, the cultured neurons were fixed with 4% paraformaldehyde/4% sucrose for 10 min at room temperature, permeabilized with 0.2% Triton X-100 in phosphate-buffered saline (PBS) for 5 min at 4°C, blocked with 3% horse serum/0.1% crystalline grade BSA in PBS for 30 min at room temperature, and incubated with the indicated primary and secondary antibodies in blocking solution for 1 h at room temperature. For overexpression of CST-3, hippocampal neurons were co-transfected with untagged full-length CST-3 expression vectors (pcDNA3.1-CST-3) and/or pEGFP-N1 at DIV8 and immunostained at DIV14. For neuronal infections with either CST expression vectors or shRNA vectors, hippocampal neurons were infected with the lentiviruses as indicated at DIV3-4 and immunostained at DIV14, as shown in the figure legends. The transfected or infected neurons were randomly chosen and images were acquired using a confocal microscope (LSM710; Carl Zeiss) with a 63× objective lenses; all image settings were kept constant. The Z-stack images obtained through confocal microscopy were converted to maximal projection and analyzed to obtain the size and density of the presynaptic terminals or postsynaptic densities using MetaMorph software (Molecular Devices). Out of focus and nondiscrete regions of staining (i.e., puncta less than 0.1 microns squared) were excluded for the analyses. For the analysis of spine density, spines were defined as dendritic protrusions of 0.5-3 μm in length. The length of each spine was measured by manually drawing a vertical line from the base of the neck to the furthest point on the spine head, and spine width was measured by drawing a maximal line perpendicular to the length line in the spine head. All analyses were performed in a blind manner.
In Utero Electroporation. Pregnant ICR mice at 15 days post coitum (d.p.c) were
anesthetized with an intraperitoneal injection of pentobarbital sodium (64.8 mg/kg), and the uterine horns were exposed through a longitudinal incision (~2-cm) in the abdomen.
Approximately 1 μl of DNA solution containing 1 mg/ml pCAGGS-EGFP, 1.5 mg/ml L-315-CST-TKD shRNA, and 0.01% Fast Green in PBS or 1 mg/ml pCAGGS-EGFP, 1.5 mg/ml L-315 control shRNA, and 0.01% Fast Green in PBS, was injected into the lateral ventricle of each embryo through a glass capillary electrode. The head of each embryo was placed between tweezer-type electrodes (CUY650P5; NEPA Gene). An electrode was placed on the injection side for the transfection of layer 2/3 pyramidal neurons in the somatosensory cortex, whereas an anode was placed at this position for the transfection of hippocampal CA1 pyramidal neurons. Square electric pulses (35 V, 50 ms) were administered four times at 1 Hz using an electroporator (CUY21; NEPA Gene). The uteri were returned to the peritoneal cavity, and the incisions were sutured. The operated mice were returned to their home cages and subsequently allowed to deliver naturally. The transfected pups were identified at P 0 by visualizing the GFP signals through the scalp using an LED penlight (Handy Blue; Reryon).
Electrophysiology. Cell culture electrophysiology was performed as previously described (Maximov et al., 2007; Xu et al., 2009) . Briefly, recordings were performed using DIV14-16 hippocampal cultured neurons. For recording mEPSC, the neurons were patched with the following internal solution (in mM): 90 Cs-gluconate, 10 CsCl, 10 HEPES, 10 EGTA, 5 NaCl, 4 Mg-ATP, and 0.3 Na-GTP. For mIPSC, the internal solution was (in mM) 100 CsCl, 5 NaCl, 10 EGTA, 10 HEPES, 4 Mg-ATP, and 0.3 Na-GTP. The recordings were performed in artificial cerebrospinal fluid (ACSF) with the following composition (in mM): 100 NaCl, 4 KCl, 1 NaH 2 PO 4 , 20 HEPES, 30 glucose, 2 CaCl 2 , and 1 MgCl 2 . Internal solutions were saturated with 95% O 2 /5% CO 2 . mEPSC and mIPSC were recorded at a holding potential of -70 mV in the presence of 1 μM tetrodotoxin (TTX; Ascent) and 100 μM picrotoxin (for mEPSCs) or 1 μM TTX and 10 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; for mIPSC). The experimenter was blinded to the identity of the constructs throughout data collection and analysis. The slice electrophysiological recordings were performed as previously described Sugita et al., 2001) . Briefly, P14-P19 mouse brains were removed and immediately immersed for 1 min in ice-cold ACSF (in mM: 119 NaCl, 2.5 KCl, 1 NaH 2 PO 4 , 26 NaHCO 3 , 10 glucose, 2.5 CaCl 2 , and 1.3 MgCl 2 ) saturated with 95% O 2 /5% CO 2 . The chilled brain was dissected to remove the olfactory bulb and cerebellum, and subsequently bonded onto a metal platform and placed in the chamber of a vibratome (Campden 7000 smz) filled with ice-cold slicing solution (in mM: 238 sucrose, 10 glucose, 26 NaHCO 3 , 1 NaH 2 PO 4 , 2.5
KCl, 3.3 MgCl 2 , and 0.5 CaCl 2 ). Coronal sections (0.35 mm thick) were sliced and transferred to a chamber containing ACSF for recovery, with an initial incubation at 34°C for Statistics. All data are expressed as the means ± SEM. All experiments were performed with at least three independent cultures and statistically evaluated using Student's t-test and one-way ANOVA, with cell numbers as the basis for 'n'.
